We investigate new products (drugs, nutraceuticals, etc.) and medical technologies through clinical trials with patients suffering from osteoarthritis.
Despite the high prevalence of this disease, the therapeutic options available are few and most address drug treatment from a symptomatic point of view only, for example, through the administration of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), whose chronic use in elderly people it entails important cardiovascular, gastrointestinal, hepatic and renal side effects.
At OAFI we are currently collaborating in the following clinical trials:
A new injectable treatment in the population with knee osteoarthritis.
A drug for the improvement of hand osteoarthritis, a pathology for which, to date, there are no specific treatments.
#ElCorazónDeTuArtrosis AECOSAR Artrosis Artrosis y Comorbilidades Artrosis y ECV Artrosis y enfermedades cardiovasculares Calidad de Vida cardiovascular cardiovascular risk comorbilidades Concienciación cuidado de los huesos dolor estructura ósea Fundación Internacional de la Artrosis Fundación OAFI huesos huesos sanos Investigación Joint Health José Luis Llisterri Medicina Comunitaria OAFI OAFI Foundation OAFI with You OA Patients OA Press release Osteoarthritis Osteoarthritis and cardiovascular Osteoarthritis and cardiovascular diseases Osteoarthritis and CVDs Osteoporosis Patient Prevención Salud Articular Salud ósea SEMERGEN VD vitamina D Vitamina D y osteoporosis Vitamin D Vitamin D and osteoarthritis Vitamin D and osteoporosis World OA Day World Osteoarthritis Day
BECOME A PARTNER
Help us improve the quality of life of osteoarthritis patients by becoming a partner.
BECOME A VOLUNTEER
The patient is the reason for being OAFI, become a volunteer and help us improve their quality of life.
MAKE A DONATION
Your help is very important to us, with it we can finance our founding work.